Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Reexamination Certificate
2005-03-29
2005-03-29
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
C514S018700, C514S019300, C546S134000, C546S153000, C548S535000
Reexamination Certificate
active
06872805
ABSTRACT:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
REFERENCES:
patent: WO 0009543 (2000-02-01), None
patent: WO 03064416 (2003-08-01), None
patent: WO 03064455 (2003-08-01), None
patent: WO 03064456 (2003-08-01), None
patent: WO 03066103 (2003-08-01), None
Q.-L. Choo, et al., “Isolation of a cDNA Clone Derived from a Bloodborne Non-A, Non-B Viral Hepatitis Genome”,Science, 244, p. 359-362 (1989).
G. Kuo, et al., “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis”,Science, 244, p. 362-364 (1989).
Campbell Jeffrey Allen
Good Andrew
Bristol--Myers Squibb Company
Chin Jennifer T.
Lukton David
Weber Jon
LandOfFree
Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3418094